APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Lyme Disease Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Veterinary Lyme Disease Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025184 pages

Choose your research edition.

Industry ResearchVeterinary Lyme Disease Vaccine Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Lyme Disease Vaccine Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Veterinary Lyme Disease Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Lyme Disease Vaccine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Lyme Disease Vaccine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Veterinary Lyme Disease Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Veterinary Lyme Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Veterinary Lyme Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary Lyme Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Veterinary Lyme Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Veterinary Lyme Disease Vaccine include Bioveta, Zoetis, Boehringer Ingelheim, Elanco and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Veterinary Lyme Disease Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Veterinary Lyme Disease Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary Lyme Disease Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Veterinary Lyme Disease Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Veterinary Lyme Disease Vaccine Segment by Company

Bioveta

Zoetis

Boehringer Ingelheim

Elanco

Merck

Veterinary Lyme Disease Vaccine Segment by Type

Monovalent Vaccines

Combination Vaccines

Veterinary Lyme Disease Vaccine Segment by Application

Canine

Feline

Others

Veterinary Lyme Disease Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Lyme Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Lyme Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Lyme Disease Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Veterinary Lyme Disease Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Veterinary Lyme Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Veterinary Lyme Disease Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Veterinary Lyme Disease Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Veterinary Lyme Disease Vaccine Industry Trends Table 2. Veterinary Lyme Disease Vaccine Industry Drivers Table 3. Veterinary Lyme Disease Vaccine Industry Opportunities and Challenges Table 4. Veterinary Lyme Disease Vaccine Industry Restraints Table 5. Global Veterinary Lyme Disease Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Veterinary Lyme Disease Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Veterinary Lyme Disease Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Veterinary Lyme Disease Vaccine Sales Market Share by Manufacturers Table 9. Global Veterinary Lyme Disease Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Veterinary Lyme Disease Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Veterinary Lyme Disease Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Veterinary Lyme Disease Vaccine Manufacturers, Product Type & Application Table 13. Global Veterinary Lyme Disease Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Veterinary Lyme Disease Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Monovalent Vaccines Table 17. Major Manufacturers of Combination Vaccines Table 18. Global Veterinary Lyme Disease Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Veterinary Lyme Disease Vaccine Sales by Type (2021-2026) & (K Units) Table 20. Global Veterinary Lyme Disease Vaccine Sales by Type (2027-2032) & (K Units) Table 21. Global Veterinary Lyme Disease Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Veterinary Lyme Disease Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Veterinary Lyme Disease Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Veterinary Lyme Disease Vaccine Revenue by Type (2021-2026) & (K Units) Table 25. Global Veterinary Lyme Disease Vaccine Revenue by Type (2027-2032) & (K Units) Table 26. Global Veterinary Lyme Disease Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Veterinary Lyme Disease Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Canine Table 29. Major Manufacturers of Feline Table 30. Major Manufacturers of Others Table 31. Global Veterinary Lyme Disease Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Veterinary Lyme Disease Vaccine Sales by Application (2021-2026) & (K Units) Table 33. Global Veterinary Lyme Disease Vaccine Sales by Application (2027-2032) & (K Units) Table 34. Global Veterinary Lyme Disease Vaccine Sales Market Share by Application (2021-2026) Table 35. Global Veterinary Lyme Disease Vaccine Sales Market Share by Application (2027-2032) Table 36. Global Veterinary Lyme Disease Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Veterinary Lyme Disease Vaccine Revenue by Application (2021-2026) & (K Units) Table 38. Global Veterinary Lyme Disease Vaccine Revenue by Application (2027-2032) & (K Units) Table 39. Global Veterinary Lyme Disease Vaccine Revenue Market Share by Application (2021-2026) Table 40. Global Veterinary Lyme Disease Vaccine Revenue Market Share by Application (2027-2032) Table 41. Global Veterinary Lyme Disease Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Veterinary Lyme Disease Vaccine Sales by Region (2021-2026) & (K Units) Table 43. Global Veterinary Lyme Disease Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Veterinary Lyme Disease Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Veterinary Lyme Disease Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Veterinary Lyme Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Veterinary Lyme Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 48. North America Veterinary Lyme Disease Vaccine Sales by Country (2027-2032) & (K Units) Table 49. Europe Veterinary Lyme Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Veterinary Lyme Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 51. Europe Veterinary Lyme Disease Vaccine Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Veterinary Lyme Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Veterinary Lyme Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Veterinary Lyme Disease Vaccine Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Veterinary Lyme Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Veterinary Lyme Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Veterinary Lyme Disease Vaccine Sales by Country (2027-2032) & (K Units) Table 58. Global Veterinary Lyme Disease Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Veterinary Lyme Disease Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Veterinary Lyme Disease Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Veterinary Lyme Disease Vaccine Revenue Market Share by Region (2021-2026) Table 62. Global Veterinary Lyme Disease Vaccine Revenue Market Share by Region (2027-2032) Table 63. Bioveta Company Information Table 64. Bioveta Business Overview Table 65. Bioveta Veterinary Lyme Disease Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Bioveta Veterinary Lyme Disease Vaccine Product Portfolio Table 67. Bioveta Recent Development Table 68. Zoetis Company Information Table 69. Zoetis Business Overview Table 70. Zoetis Veterinary Lyme Disease Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Zoetis Veterinary Lyme Disease Vaccine Product Portfolio Table 72. Zoetis Recent Development Table 73. Boehringer Ingelheim Company Information Table 74. Boehringer Ingelheim Business Overview Table 75. Boehringer Ingelheim Veterinary Lyme Disease Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Boehringer Ingelheim Veterinary Lyme Disease Vaccine Product Portfolio Table 77. Boehringer Ingelheim Recent Development Table 78. Elanco Company Information Table 79. Elanco Business Overview Table 80. Elanco Veterinary Lyme Disease Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Elanco Veterinary Lyme Disease Vaccine Product Portfolio Table 82. Elanco Recent Development Table 83. Merck Company Information Table 84. Merck Business Overview Table 85. Merck Veterinary Lyme Disease Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Merck Veterinary Lyme Disease Vaccine Product Portfolio Table 87. Merck Recent Development Table 88. Key Raw Materials Table 89. Raw Materials Key Suppliers Table 90. Veterinary Lyme Disease Vaccine Distributors List Table 91. Veterinary Lyme Disease Vaccine Customers List Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. Veterinary Lyme Disease Vaccine Product Image Figure 2. Global Veterinary Lyme Disease Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Lyme Disease Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Veterinary Lyme Disease Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Veterinary Lyme Disease Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Veterinary Lyme Disease Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Monovalent Vaccines Image Figure 9. Combination Vaccines Image Figure 10. Global Veterinary Lyme Disease Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Veterinary Lyme Disease Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Veterinary Lyme Disease Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Veterinary Lyme Disease Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Veterinary Lyme Disease Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Veterinary Lyme Disease Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Canine Image Figure 17. Feline Image Figure 18. Others Image Figure 19. Global Veterinary Lyme Disease Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Veterinary Lyme Disease Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Veterinary Lyme Disease Vaccine Sales Market Share by Application (2021-2032) Figure 22. Global Veterinary Lyme Disease Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Veterinary Lyme Disease Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Veterinary Lyme Disease Vaccine Revenue Market Share by Application (2021-2032) Figure 25. North America Veterinary Lyme Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Veterinary Lyme Disease Vaccine Sales Market Share by Country (2021-2032) Figure 27. U.S. Veterinary Lyme Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Veterinary Lyme Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Veterinary Lyme Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Veterinary Lyme Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Veterinary Lyme Disease Vaccine Sales Market Share by Country (2021-2032) Figure 32. Germany Veterinary Lyme Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Veterinary Lyme Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Veterinary Lyme Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Veterinary Lyme Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Veterinary Lyme Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Veterinary Lyme Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Veterinary Lyme Disease Vaccine Sales Market Share by Country (2021-2032) Figure 39. China Veterinary Lyme Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Veterinary Lyme Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Veterinary Lyme Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Veterinary Lyme Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Veterinary Lyme Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Veterinary Lyme Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Veterinary Lyme Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Veterinary Lyme Disease Vaccine Sales Market Share by Country (2021-2032) Figure 47. Brazil Veterinary Lyme Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Veterinary Lyme Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Veterinary Lyme Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Veterinary Lyme Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Veterinary Lyme Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Veterinary Lyme Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Veterinary Lyme Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Veterinary Lyme Disease Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Veterinary Lyme Disease Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Veterinary Lyme Disease Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Veterinary Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Figure 58. North America Veterinary Lyme Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Veterinary Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Veterinary Lyme Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Veterinary Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Veterinary Lyme Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Veterinary Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Veterinary Lyme Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Veterinary Lyme Disease Vaccine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Veterinary Lyme Disease Vaccine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Monovalent Vaccines
  • Combination Vaccines
Applications
  • Canine
  • Feline
  • Others
Companies covered
  • Bioveta
  • Zoetis
  • Boehringer Ingelheim
  • Elanco
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Veterinary Lyme Disease Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Veterinary Lyme Disease Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Veterinary Lyme Disease Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Veterinary Lyme Disease Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Veterinary Lyme Disease Vaccine Market Dynamics
  1. 2.1 Veterinary Lyme Disease Vaccine Industry Trends
  2. 2.2 Veterinary Lyme Disease Vaccine Industry Drivers
  3. 2.3 Veterinary Lyme Disease Vaccine Industry Opportunities and Challenges
  4. 2.4 Veterinary Lyme Disease Vaccine Industry Restraints
3 Veterinary Lyme Disease Vaccine Market by Manufacturers
  1. 3.1 Global Veterinary Lyme Disease Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Veterinary Lyme Disease Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Veterinary Lyme Disease Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Veterinary Lyme Disease Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Veterinary Lyme Disease Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Veterinary Lyme Disease Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Veterinary Lyme Disease Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Veterinary Lyme Disease Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Veterinary Lyme Disease Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Veterinary Lyme Disease Vaccine Tier 1, Tier 2, and Tier 3
4 Veterinary Lyme Disease Vaccine Market by Type
  1. 4.1 Veterinary Lyme Disease Vaccine Type Introduction
  2. 4.1.1 Monovalent Vaccines
  3. 4.1.2 Combination Vaccines
  4. 4.2 Global Veterinary Lyme Disease Vaccine Sales by Type
  5. 4.2.1 Global Veterinary Lyme Disease Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Veterinary Lyme Disease Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Veterinary Lyme Disease Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Veterinary Lyme Disease Vaccine Revenue by Type
  9. 4.3.1 Global Veterinary Lyme Disease Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Veterinary Lyme Disease Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Veterinary Lyme Disease Vaccine Revenue Market Share by Type (2021-2032)
5 Veterinary Lyme Disease Vaccine Market by Application
  1. 5.1 Veterinary Lyme Disease Vaccine Application Introduction
  2. 5.1.1 Canine
  3. 5.1.2 Feline
  4. 5.1.3 Others
  5. 5.2 Global Veterinary Lyme Disease Vaccine Sales by Application
  6. 5.2.1 Global Veterinary Lyme Disease Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Veterinary Lyme Disease Vaccine Sales by Application (2021-2032)
  8. 5.2.3 Global Veterinary Lyme Disease Vaccine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Veterinary Lyme Disease Vaccine Revenue by Application
  10. 5.3.1 Global Veterinary Lyme Disease Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Veterinary Lyme Disease Vaccine Revenue by Application (2021-2032)
  12. 5.3.3 Global Veterinary Lyme Disease Vaccine Revenue Market Share by Application (2021-2032)
6 Global Veterinary Lyme Disease Vaccine Sales by Region
  1. 6.1 Global Veterinary Lyme Disease Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Veterinary Lyme Disease Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Veterinary Lyme Disease Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Veterinary Lyme Disease Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Veterinary Lyme Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Veterinary Lyme Disease Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Veterinary Lyme Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Veterinary Lyme Disease Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Veterinary Lyme Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Veterinary Lyme Disease Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Veterinary Lyme Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Veterinary Lyme Disease Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Veterinary Lyme Disease Vaccine Revenue by Region
  1. 7.1 Global Veterinary Lyme Disease Vaccine Revenue by Region
  2. 7.1.1 Global Veterinary Lyme Disease Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Veterinary Lyme Disease Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Veterinary Lyme Disease Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Veterinary Lyme Disease Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Veterinary Lyme Disease Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Veterinary Lyme Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Veterinary Lyme Disease Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Veterinary Lyme Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Veterinary Lyme Disease Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Veterinary Lyme Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Veterinary Lyme Disease Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Veterinary Lyme Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Bioveta
  2. 8.1.1 Bioveta Company Information
  3. 8.1.2 Bioveta Business Overview
  4. 8.1.3 Bioveta Veterinary Lyme Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bioveta Veterinary Lyme Disease Vaccine Product Portfolio
  6. 8.1.5 Bioveta Recent Developments
  7. 8.2 Zoetis
  8. 8.2.1 Zoetis Company Information
  9. 8.2.2 Zoetis Business Overview
  10. 8.2.3 Zoetis Veterinary Lyme Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zoetis Veterinary Lyme Disease Vaccine Product Portfolio
  12. 8.2.5 Zoetis Recent Developments
  13. 8.3 Boehringer Ingelheim
  14. 8.3.1 Boehringer Ingelheim Company Information
  15. 8.3.2 Boehringer Ingelheim Business Overview
  16. 8.3.3 Boehringer Ingelheim Veterinary Lyme Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Boehringer Ingelheim Veterinary Lyme Disease Vaccine Product Portfolio
  18. 8.3.5 Boehringer Ingelheim Recent Developments
  19. 8.4 Elanco
  20. 8.4.1 Elanco Company Information
  21. 8.4.2 Elanco Business Overview
  22. 8.4.3 Elanco Veterinary Lyme Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Elanco Veterinary Lyme Disease Vaccine Product Portfolio
  24. 8.4.5 Elanco Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Veterinary Lyme Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merck Veterinary Lyme Disease Vaccine Product Portfolio
  30. 8.5.5 Merck Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Veterinary Lyme Disease Vaccine Value Chain Analysis
  2. 9.1.1 Veterinary Lyme Disease Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Veterinary Lyme Disease Vaccine Production Mode & Process
  6. 9.2 Veterinary Lyme Disease Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Veterinary Lyme Disease Vaccine Distributors
  9. 9.2.3 Veterinary Lyme Disease Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst